Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

Adult Patients:877-442-3324

Pediatric Patients:888-733-4662

Make Appointment OnlineInternational Patients

Online second opinions

Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.

Request a second opinion

Contact & Directions

Email Dana-Farber

Main Number617-632-3000

Toll-Free Number866-408-DFCI (3324)

Maps & DirectionsContact InformationSend us a Question or Comment

How to Help

Discover the ways to give and how to get involved to support Dana-Farber.

Learn More
Give now

News Releases

  •   Email
  •   Print
  •   Share

  • Judy E. Garber, MD, MPH, director of the Center for Cancer Genetics and Prevention at Dana-Farber, has been honored by the American Association for Cancer Research for outstanding achievement in clinical cancer research.

Tags: Honors

  • David M. Livingston, MD, of Dana-Farber, has won a major award for discoveries in cancer research from the American Association for Cancer Research.

Tags: Honors

  • On behalf of cancer patients everywhere, I am relieved that the House of Representatives did not put forward its health care bill.

  • Dana-Farber Cancer Institute and Lifespan signed a strategic alliance agreement to advance cancer treatment and research supporting the expansion of clinical trials, access for Lifespan physicians to cancer-specific disease expertise for complex cases, and creating a program to coordinate the treatment of bone marrow transplant patients, with transplants provided in Boston at Dana-Farber/Brigham and Women’s Cancer Center and care surrounding the transplant in Rhode Island at at Lifespan.

Tags: Partnerships

  • We are deeply concerned about the Administration's budget proposal, which includes a $5.8 billion cut in support for the National Institutes of Health (NIH). This proposed cut would be a disaster for researchers, and for people with cancer and other diseases.

Tags: Funding

  • A number of Dana-Farber Cancer Institute faculty are presenting abstracts at the 2017 American Association for Cancer Research (AACR) Annual Meeting being held April 1-5, 2017 in Washington, DC.

Tags: Immunotherapy

  • Dana-Farber scientists report that a compound able to reverse the allegiance of innate immune system cells – turning them from tumor enablers into tumor opponents – caused breast tumors in mice to shrink and withdraw from distant metastases.

Tags: ImmuneSystem, Immunotherapy

  • Spurred by research led by scientists at Dana-Farber, the Food and Drug Administration has approved the first oral treatment for carcinoid syndrome diarrhea, a rare but potentially debilitating condition in patients with neuroendocrine tumors.

Tags: CopingWithCancer

  • rian Wolpin, MD, MPH, has been appointed Robert T. and Judith B. Hale Chair in Pancreatic Cancer at Dana-Farber Cancer Institute.

Tags: Appointments, ColonCancer

  • A major clinical trial led by researchers at Dana-Farber has shown that a novel agent can protect against the most common viral infection patients face after transplantation.

Tags: StemCellTransplant

Showing 1-10 of 762 items